Hidradenitis suppurativa: A disease with male predominance in Tunisia

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 18, Issue 4, 2009, Pages 165-172

  Mebazaa, Amel ^a   Hadid, Rym Ben ^a   Rouhou, R Cheikh ^a   Trojjet, Sondes ^a   El Euch, Dalenda ^a   Mokni, Mourad ^a   Zitouna, Moncef ^a   Osman, Amel Ben ^a  

^a LA RABTA HOSPITAL   (Tunisia)

Author keywords

Acne inversa; Hidradenitis suppurativa; Verneuil

Indexed keywords

DOXYCYCLINE; ERYTHROMYCIN; ETRETIN; ISOTRETINOIN; OXACILLIN; RETINOID; RIFAMPICIN;

ABSCESS; ADULT; ANTIBIOTIC THERAPY; ANUS; ARTICLE; AXILLA; CLINICAL ARTICLE; CLINICAL FEATURE; COMEDO; DARIER DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE PREDISPOSITION; DOWN SYNDROME; EPIDEMIOLOGICAL DATA; FEMALE; FIBROSIS; FOLLICULITIS; FOLLOW UP; GENITAL SYSTEM; GRANULOMA; HISTOLOGY; HUMAN; HYDROCELE; MALE; PAPULE; PERINEUM; PROGNOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; SKIN NODULE; SKIN ULCER; STAPHYLOCOCCUS; SUPPURATIVE HIDRADENITIS; TESTIS; TUNISIA; VAGINAL HYDROCELE;

ADULT; FEMALE; HIDRADENITIS SUPPURATIVA; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TUNISIA; YOUNG ADULT;

EID: 76149094172     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Verneuil A. Etudes sur les tumeurs de la peau et quelques maladies des glandes sudoripares. Arch Gen Med. 1854;4:447-68, 693-704.
2. Pillsbury DM, Shelly WB, Kligman AM. Bacterial infections of the skin. In: Pillsbury DM, editor. Dermatology, 1st ed. Philadelphia: W. B. Saunders; 1956. p. 482-4, 489.
3. Attanoos RL, Appleton MA, Douglas-Jones AG. The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands. Br J Dermatol. 1995;133:254-8.
4. T Jansen, Altmeyer P, Plewig G. Acne inversa (alias hidradenitis suppurativa). J Eur Acad Dermatol Venereol. 2001;15:532-40.
5. Jemec GBE, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol. 1996;35:191-4.
6. Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009 Apr;60(4):539-61; quiz 562-3.
7. Mengesha YM, Holcombe TC, Hansen RC. Prepubertal hidradenitis suppurativa: two case reports and review of the literature. Pediatr Dermatol. 1999;16:292-6.
8. Paletta C, Jurkiewicz MJ. Hidradenitis suppurativa. Clin Plast Surg. 1987;14:383-90.
9. Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. In: Roenigk RK, Roenigk HH, editors. Dermatologic surgery. New York: Marcel Dekker; 1989. p. 729-39.
10. Sartorius K, Lapins J, Emtestam L, Jemec GB. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol. 2003;149:211-3.
11. Jemec GB, Hansen U. Histology of hidradenitis suppurativa. J Am Acad Dermatol. 1996;34:994-9.
12. Yu CC, Cook MG. Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands. Br J Dermatol. 1990;122:763-9.
13. Jemec GB, Faber M, Gutschik E, Wendelboe P. The bacteriology of hidradenitis suppurativa. Dermatology. 1996;193:203-6.
14. Lapins J, Jarstrand C, Emtestam L. Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br J Dermatol. 1999;140:90-5.
15. Kelly AM, Cronin P. MRI features of hidradenitis suppurativa and review of the literature. AJR Am J Roentgenol. 2005;185:1201-4.
16. Wortsman X, Jemec GBE. Real-time compound imaging ultrasound of hidradenitis suppurativa. Dermatol Surg.2007;33(11):1340-2.
17. O'Loughlin S, Woods R, Kirke PN, et al. Hidradenitis suppurativa. Glucose tolerance, clinical, microbiologic, and immunologic features and HLA frequencies in 27 patients. Arch Dermatol. 1988;124:1043-6.
18. Fitzsimmons JS, Fitzsimmons EM, Bilbert G. Familial hidradenitis suppurativa: evidence in favour of single gene transmission. J Med Genet. 1984;21:281-5.
19. Mortimer PS, Dawber RPR, Gales MA, Moore RA. Mediation of hidradenitis suppurativa by androgens. Br Med J. 1986;292:245-8.
20. Yosipovitch G, DeVore A, Dawn A. Obesity and the skin: skin physiology and skin manifestations of obesity. J Am Acad Dermatol. 2007 Jun;56(6):901-16; quiz 917-20.
21. König A, Lehman C, Rompel R, et al. Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology. 1999;198:261-4.
22. Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F, Poli F, Faye O, Roujeau JC, Bonnelye G, Grob JJ, Bastuji-Garin S. Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies. J Am Acad Dermatol. 2008;59:596-601.
23. Morgan WP, Leicester G. The role of depilation and deodorants in hidradenitis suppurativa. Arch Dermatol. 1982;118:101-2.
24. Stellon AJ, Wakeling M. Hidradenitis suppurativa associated with use of oral contraceptives. Br Med J. 1989;298:28-9.
25. Jemec GBE, Faber M, Gutschick E, et al. Microbiology of hidradenitis suppurativa. Dermatology. 1996;193:203-6.
26. Roy MK, Appleton MAC, Delicata RJ, Sharma AK, et al. Probable association between hidradenitis suppurativa and Crohn's disease: significance of epithelioid granuloma. Br J Surg. 1997;84:375-6.
27. Church JM, Fazio VW, Lavery IC, Oakley JR, Milsom JW. The differential diagnosis and comorbidity of hidradenitis suppurativa and perianal Crohn's disease. Int J Colorectal Dis. 1993;8:117-9.
28. Von der Werth JM, Jemec GBE. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol. 2001;144:809-13.
29. Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz J. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol. 2007 Apr;56(4):621-3.
30. Diaz D, Calvo-Serrano M, Martinez-Hijosa E, et al. Squamous cell carcinoma complicating perianal hidradenitis suppurativa. Int J Colored Dis. 1995;10:225-8.
31. Slah N. Hidradenitis suppurativa: a treatment challenge. Am Fam Physician. 2005;72(8):1547-52.
32. Jemec GB, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 1998;39:971-4.
33. Mortimer PS, Dawber RP, Gales MA, Moore RA. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol. 1986;115:263-8.
34. Farrell AM, Randall VA, Vafaee T, Dawber RP. Finasteride as a therapy for hidradenitis suppurativa. Br J Dermatol. 1999;141:1138-9.
35. Boer J, van Genert MJP. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J Am Acad Dermatol. 1990;40:73-6.
36. Chow E, Mortimer P. Successful treatment of hidradenitis suppurativa on retroauricular acne with etretinate. Br J Dermatol. 1992;126:415-9.
37. Sullivan TP, Welsh E, Kerdel FA et al. Infliximab for hidradenitis suppurativa. Br J Dermatol. 2003;149:1046-9.
38. Cusack C, Buckley C. Etanercept: effective in the management of hidradenitis suppurativa. Br J Dermatol. 2006;154:726-9.
39. Frohlich D, Baaske D, Glatzel M. Radiotherapy of hidradenitis suppurativa-still valid today? Strahlenther Onkol. 2000;176:286-9.
40. Gold MH. Aminolevulinic acid photodynamic therapy for hidradenitis suppurativa. Dermatol Clin. 2007 Jan;25(1):67-73.
41. Lapins J, Sartorius K, Emtestam L. Scanner-assisted carbon dioxide laser surgery: a retrospective follow-up study of patients with hidradenitis suppurativa. J Am Acad Dermatol. 2002;47:280-5.
42. Slade DE, Powell BW, Mortimer PS. Hidradenitis suppurativa: pathogenesis and management. Br J Plast Surg. 2003;56:451-61.